📢 Publish Your Research for Free - Full APC Waiver, No Hidden Charges. Submit Your Article Today! Submit Now →
JImage

ARTICLE TYPE : REVIEW ARTICLE

Published on :   12 Nov 2026, Volume - 2
Journal Title :   WebLog Journal of Microbiology | WebLog J Microbiol | WJM
Source URL:   weblog icon https://weblogoa.com/articles/wjm.2026.k1202
Permanent Identifier (DOI) :   doi icon https://doi.org/10.5281/zenodo.24246939

Next-Generation Vaccinology Against Antimicrobial- Resistant Pathogens: Advances, Challenges, and Future One Health Perspectives

Nweje-Anyalowu Paul Chukwuemeka 1 *
Auwal Shehu Ali 2
Isaiah Zephaniah 3
Mathew Taiye Moses 4
Umar Muhammed Muhsin 5
Amodu Godwin 6
Idakwoji Precious 7
1Biochemistry Programme, Department of Chemical Sciences, Faculty of Science, Clifford University, Owerrinta (Ihie Campus), Abia State, Nigeria
2Federal Teaching Hospital, Katsina, Katsina State, Nigeria
3Department of Health Biotechnology, University of Calabria, Italy
4Federal Medical Centre, Keffi, Nassarawa State, Nigeria
5Department of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano State, Nigeria
6Department of Biochemistry, Federal University Lokoja, Lokoja, Kogi State, Nigeria
7Department of Biochemistry, Faculty of Natural Sciences, Prince Abubakar Audu University, Anyigba, Kogi State, Nigeria

Abstract

Background: Antimicrobial Resistance (AMR) has emerged as a defining global health challenge, threatening the effectiveness of existing therapeutics and reversing gains in infectious disease control. Vaccination offers a preventive strategy that reduces infection incidence, limits antimicrobial use, and slows the emergence of resistant strains.

Objective: This review examines recent advances in next-generation vaccinology targeting antimicrobial-resistant pathogens, highlighting technological innovations, translational barriers, and future directions within a One Health framework.

Methods: A narrative synthesis of recent literature (2021-2026) was undertaken, focusing on emerging vaccine platforms, immunological strategies, and policy-oriented approaches relevant to AMR mitigation.

Results: Novel vaccine technologies, including mRNA, DNA, viral vector, and nanoparticle-based systems, have expanded the scope of vaccinology beyond traditional paradigms. Epitope-based design, reverse vaccinology, and systems immunology approaches are improving antigen selection and immunogenicity. These advances are complemented by increasing recognition of vaccines as tools to reduce antibiotic consumption and interrupt transmission of resistant pathogens. Despite progress, several challenges persist, including antigenic variability, limited correlates of protection, high development costs, and regulatory complexities. In addition, disparities in vaccine access and implementation, particularly in low- and middle-income settings, constrain global impact.

Conclusion: Next-generation vaccines represent a critical yet underutilized strategy in combating AMR. Their integration into broader One Health initiatives, alongside strengthened surveillance, policy alignment, and equitable distribution, will be essential for sustainable impact. Continued investment in interdisciplinary research and innovative development pathways is required to translate scientific advances into effective public health interventions.

Keywords: Vaccinology; Antimicrobial-Resistant; Pathogens; Advances; Challenges; One Health

Citation

Nweje-Anyalowu PC, Auwal SA, Isaiah Z, Mathew TM, Umar MM, Amodu G, et al. Next-Generation Vaccinology Against Antimicrobial- Resistant Pathogens: Advances, Challenges, and Future One Health Perspectives. WebLog J Microbiol. wjm.2026.k1202. https://doi.org/10.5281/zenodo.24246939